| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kronos Bio, Inc. | SR VP, CLINICAL SCIENCE | Common Stock | 193,275 | $203,693 | $1.05 | 21 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KRON | Kronos Bio, Inc. | 21 Feb 2024 | 1 | -$7,765 | 4 | SR VP, CLINICAL SCIENCE | 23 Feb 2024, 20:12 |
| KRON | Kronos Bio, Inc. | 16 Feb 2024 | 0 | $0 | 3 | SR VP, CLINICAL SCIENCE | 23 Feb 2024, 20:09 |